Recombinant Pseudomonas cichorii DTE Protein，His & Myc

DTE (Dipeptidyl Peptidase IV, also known as DPP-4) is a key enzyme involved in various physiological processes, including glucose metabolism, immune response, and cellular signaling. Its role in the inactivation of several bioactive peptides, such as incretins, has made it a target of significant interest in diabetes research, particularly in the context of type 2 diabetes management. Recent studies have highlighted the importance of DTE's structural and functional characteristics, as they can influence substrate specificity and enzymatic activity. Advances in recombinant DNA technology have enabled the production of modified DTE proteins, allowing researchers to explore their potential therapeutic applications, including as inhibitors in diabetic therapies and modulators of immune responses. The investigation of DTE's role extends beyond diabetes; its implications in cancer biology and cardiovascular health have started to emerge, underscoring the necessity for a deeper understanding of its mechanisms. As the field advances, there is a growing emphasis on structure-function relationships, which could pave the way for novel therapeutic strategies targeting DTE and related pathways, ultimately improving health outcomes in various diseases.